Iowa City, IA, United States of America

Kristina W Thiel

This inventor holds 1 USPTO granted patent and 2 published patent applications. Top assignee: University of Iowa Research Foundation. Active years: 2015.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Kristina W Thiel. Retrieved from https://idiyas.com/inventor/kristina-w-thiel

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 1 

% Patents Active = 100.0

Average Co-Inventor Count = 5.0

ph-index = 1

Forward Citations = 1(Granted Patents)


Company Filing History:


Years Active: 2015

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Innovator Kristina W. Thiel: Pioneering HER2 Nucleic Acid Aptamers

Introduction

Kristina W. Thiel is an accomplished inventor based in Iowa City, IA. She has made significant contributions to the field of biotechnology, particularly in the development of nucleic acid aptamers. Her work focuses on optimizing HER2 aptamers, which have important applications in cancer research and treatment.

Latest Patents

Kristina holds a patent for HER2 nucleic acid aptamers. The present invention relates to optimized HER2 aptamers and methods of using these aptamers. This innovation represents a crucial advancement in targeted therapies for HER2-positive cancers.

Career Highlights

Kristina is affiliated with the University of Iowa Research Foundation, where she continues to advance her research. Her dedication to scientific inquiry and innovation has positioned her as a key figure in her field.

Collaborations

Throughout her career, Kristina has collaborated with notable colleagues, including James O. McNamara and Paloma H. Giangrande. These partnerships have enriched her research and contributed to the success of her projects.

Conclusion

Kristina W. Thiel's work in developing HER2 nucleic acid aptamers showcases her innovative spirit and commitment to advancing cancer treatment. Her contributions to biotechnology are invaluable and continue to inspire future research.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…